Skip to content

Clinical trials

Phase 3 Liver Cirrhosis, Biliary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 3 Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20092
20121
20166
20171
20181
20203
20214
20234
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting9
Unknown status7
Active, not recruiting5
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xijing Hospital of Digestive Diseases8
Gilead Sciences5
Ipsen4
GlaxoSmithKline3
Zydus Therapeutics Inc.3
Intercept Pharmaceuticals2
National Center for Research Resources (NCRR)2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Beijing Friendship Hospital1
Cascade Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary38
Cholestasis4
Fibrosis3
Pruritus3
Gastrointestinal Diseases2
Rare Diseases2
Atherosclerosis1
Cholangitis, Sclerosing1
Hypercholesterolemia1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.